Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05568043

The Reducing REVISITS Study: A Cluster RCT

Led by University of Chicago · Updated on 2025-06-06

24

Participants Needed

1

Research Sites

215 weeks

Total Duration

On this page

Sponsors

U

University of Chicago

Lead Sponsor

S

Society of Hospital Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

This type II hybrid effectiveness-implementation trial will concurrently study the comparative effectiveness of virtual vs. in-person COPD care transition programs implemented via virtual mentored implementation approaches with and without co-design methods. The investigators will enroll up to 24 randomized sites (with a goal minimum of 16 sites) to: * Deliver the COPD programs implemented via mentored support in collaboration with SHM Center for Quality Improvement. * Compare the effectiveness and penetration of virtual versus in-person COPD care transition programs implemented along with mentoring support with or without co-design. The investigators aim to determine which combined approach(es) is/are the most effective at implementing evidence-based COPD program interventions and decreasing COPD acute care revisits with the greatest overall impact and sustainability.

CONDITIONS

Official Title

The Reducing REVISITS Study: A Cluster RCT

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Enrollment occurs at the hospital site or system level
  • Sites represent diverse patient populations and geographic locations across the US
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Chicago

Chicago, Illinois, United States, 60637

Actively Recruiting

Loading map...

Research Team

L

Leah Traeger

CONTACT

V

Valerie G Press, MD, MPH

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

PREVENTION

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here